• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY AG HLM TUBING SET W/BIOLINE COATING; TUBING, PUMP, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY AG HLM TUBING SET W/BIOLINE COATING; TUBING, PUMP, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BE-PLS 2050
Device Problem Occlusion Within Device (1423)
Patient Problem No Information (3190)
Event Date 04/18/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Maquet medical systems, usa submits this report on behalf of the legal manufacturer of the device maquet cardiopulmonary (b)(4).The device has been requested but not yet received.A follow-up medwatch will be submitted when additional information becomes available.
 
Event Description
According to the customer: "there was clotting inside the oxygenator within 24 hours during the ecmo period.The value of aptt is 33.1s.The rpm is 4265." (b)(6).
 
Manufacturer Narrative
Maquet cardiopulmonary (b)(4) requested the product for investigation but the product was not available.Therefore no laboratory investigation could be performed by the manufacturer.Thus the reported failure could not be confirmed.The most probable root cause of the event is not adequate anticoagulant therapy with heparin.Clinical assessment: it is an off-label use of the pls system.We have a ptt between 60 and 90 sec in the corresponding ifu.The specified value in the complaint report of 33.1 sec appt is significantly lower than this recommendation.On point 5.2 safety instructions for the extracorporeal circulation in section 4: the partial thromboplastin time (ptt) should be in the range from 60 to 90 seconds.An antithrombin iii(at iii) value in the normal range is required for reliable anticoagulant therapy with heparin.Based on these results and the information available at this time, the oxygenator in question operated within maquet cardiopulmonary specifications.Since the reported failure did not contribute to a death or serious injury and no systemic issue could be determined no corrective action is needed at this time.The data is also being handled through a designated maquet cardiopulmonary trending and applicable investigation process.Due to this no further investigation initiations will be completed at this time.
 
Event Description
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HLM TUBING SET W/BIOLINE COATING
Type of Device
TUBING, PUMP, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY AG
rastatt
GM 
Manufacturer (Section G)
BERND RAKOW
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt
GM  
Manufacturer Contact
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt 
4972229321
MDR Report Key6581811
MDR Text Key75836316
Report Number8010762-2017-00161
Device Sequence Number1
Product Code DWE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K080592
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2018
Device Model NumberBE-PLS 2050
Device Catalogue Number701027818
Device Lot Number70115328
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/02/2017
Date Device Manufactured11/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-